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1. Introduction 
Two activities of membrane-bound monoamine 
oxidase (MAO) can be distinguished in mammalian 
tissues with the aid of substrate selective inhibitors. 
A serotonin oxidising activity that is sensitive to 
Clorgyline (N-methyl-N-propargyl-3-(2,4-dichloro- 
phenoxyl)propylamine) [ 1 ] , Lilly 5 1641 (N- [2(0- 
chlorophenoxyl)-ethyl] cyclopropylamine [2] and 
PC0 (5phenyl-3-(N-cyclopropyl)ethylamine 
1,2,4-oxadiazole) [3] and a benzylamine oxidising 
activity that is sensitive to Deprenil (phenyisopropyl- 
methylpropinylamine) [4]. Tyramine, tryptamine and 
dopamine are deaminated by both systems [ 5 j . The 
nature of the two activities remains obscure. The 
concept of two distinct enzymes A and B, for the 
serotonin and benzylamine oxidising activities 
respectively, was suggested by Johnston [ 1 ] and has 
received support from several workers [6] . However 
no convincing separation of the two forms, a requisite 
for the Johnston model, has been demonstrated to 
date. Alternative models that have been suggested for 
the rat liver enzyme are a single enzyme in different 
membrane environments [7] and a two site enzyme 
[8] . Experiments to test these models are not straight- 
forward. This is partly due to the fact that none of 
these models stipulates the nature of the hypothetical 
form(s) as isolated from the membrane environment, 
and is considerably complicated by the known 
allotopic properties of the enzyme [9]. Thus the 
isolation of a clorgyline sensitive enzyme that 
deaminates serotonin but not benzylamine, before 
being assigned as MAO-A [lo] should be shown not 
to contain an inactive B protein (or subunit). The 
problem of selectively inactivating one of the two 
forms during purification is well known [ 1 l-l 3] . 
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Therefore until schemes for purifying preparations 
of MAO that can account for both forms become 
available alternative approaches to delineate the nature 
of the two forms have to be considered. 
While several developmental studies of MAO have 
been reported [14-l 71 these have generally been 
limited with respect to the substrates used and are 
consequently of little use in the context of multiple 
forms. An exception is the study by Callingham and 
Lyles [ 181 who have shown that the increase in rat 
heart MAO with age is due to an increase in the A-form 
(using the criterion of clorgyline sensitivity). It has 
recently been suggested [191 that in developing mouse 
brain the A and B forms follow different post-natal 
development patterns. This conclusion was based on 
the different rates of development of the specific 
activity of representative substrates of the two forms. 
We wish to report the results of a study on the deve- 
lopment of MAO in rat liver and brain monitoring 
the A/B ratio with the selective inhibitors Clorgyline, 
Deprenil and PC0 as well as the specific activity with 
appropriate substrates. 
2. Materials and methods 
[ 1 -I4 C] -1abelled serotonin creatinine sulphate, 
tyramine hydrochloride, dopamine hydrochloride and 
[G-3 H] tryptamine hydrochloride were obtained from 
the Radiochemical Centre, Amersham, Bucks, U.K. and 
[ l-l4 C] -1abelled benzylamine hydrochloride was 
obtained from ICN Pharmaceuticals, Irvine, Calif. 
USA. Clorgyline (M & B 9302) was a kind gift from 
May & Baker, Dagenham, Essex, U.K. and Deprenil 
and PC0 were kind gifts from Roche Products Ltd., 
Welwyn Garden City, Herts, UK. 
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2.1. Preparation of enzyme extracts 
Mitochondrial fractions from the pooled livers and 
brains of Wistar rats at various stages of development 
were stored at -20°C. Brain homogenates were used 
immediately or stored at --20°C. 
ed with regard to kinetic parameters, which for 
serotonin, tyramine, dopamine and phenylethylamine 
are similar to values obtained for whole liver (Mantle, 
Garrett and Tipton, unpublished observations). 
2.2. Monoamine oxidase activity 
MAO activity was assayed radioisotopically [3] , 
extracting deaminated products into 0.6% PPO in 
toluene/ethyl acetate (1: 1, v/v). 
3. Results and discussion 
The specific activity of foetal liver mitochondrial 
MAO (from 3 days prepartum) was similar to adult 
values (150 g and 350 g rats). Similar results were 
obtained over this developmental period when benzyl- 
amine, serotonin or dopamine were used as substrates. 
Vaccari et al. [ 141 have reported a similar result with 
kynuramine as substrate. The effect of PC0 and 
Deprenil on the tyramine deaminating activity of 
foetal liver MAO (fig.1) shows the presence of both 
forms in similar proportions to those found in adult 
tissues [2 1 ] . These results demonstrate that the 
binary system in rat liver is fully developed at least 
3 days prepartum. It is tempting to extrapolate these 
findings to rat liver parenchymal cells which have been 
shown to contain both forms of MAO in similar 
proportions to those found in whole liver 1211. In this 
connection the enzyme from these cells (a washed 
mitochondrial preparation) has been further characteris- 
In rat brain we observed a similar difference in the 
developmental patterns of the specific activity of A 
and B substrates as reported for mouse brain [ 191 . 
The most striking and quantitative demonstration of 
this delayed development of the B-form in rat brain 
came from experiments where the A/B ratio was 
determined with the aid of selective inhibitors (fig.2). 
By the criterion of Clorgyline sensitivity the foetal 
rat brain (6 days prepartum) has only 2.5-375 of the 
B-form. This proportion rises rapidly so that by day 
25 it is approaching the adult value of 32%. Similar 
results were obtained using Deprenil or PC0 with 
homogenates or washed mitochondrial fractions (fig.2). 
It is tempting to speculate that the predominance of 
the A-form in foetal rat brain may be related to 
reports from Murphy’s group that neuroblastoma [22] 
and glioma [23] contain exclusively this form. If 
cultured neuroblastoma and glioma contain only a 
foetal form of the enzyme, differentiation of these 
cells may provide a useful model for MAO development 
in the brain. Preliminary studies in this laboratory 
(Mantle and Cantin, unpublished observations) have 
confirmed the results of Murphy’s group but so far 
have been unsuccessful in inducing the B-form on 
differentiation. The attraction of such an inducible 
system for further studies on the nature and develop- 
ment of the B-form in brain is obvious. 
Fig.1. Effect of Deprenil and PC0 on the MAO activity of two 
day prepartum rat liver mitochondria. Enzyme was preincubated 
in 0.1 M phosphate buffer pH 7.2 for 30 min at 30°C with the 
concentrations of Deprenil (A) or PC0 (A) indicated, prior to 
the addition of [14C] tyramine (0.05 pCi= final concn 100 PM). 
After 20 min the reaction was terminated by the addition of 
2 M-citric acid (0.5 ml) and the deaminated product extracted 
as described in the text. No inhibition occurred during pre- 
incubation in the absence of inhibitor. Results obtained with 
clorgyline on separate preparations were in agreement with 
9 6 7 
those obtained with PC0 and curves obtained with different 
6 5 4 3 preparations using Deprenil gave plateau values that did not 
- Log [Inhibitor] differ by more than * 5%. 
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Fig.2. Age-dependence of the proportion of the B-form in rat brain. The proportion of the B-form was estimated from the 
clorgyline insensitive (A) and Deprenil sensitive (L) fraction of brain homogenates and the PC0 insensitive (a) fraction of brain 
mitochondrial fractions. MAO was assayed radioisotopically with tyramine as substrate in 0.1 M phosphate pH 7.2 The inhibitor 
concentration ranges were the same as in fig.1. Each preparation represented pooled foetal brains from 2-4 dams or 2-4 litters. 
The plateau values were each obtained from dose-response curves using not less than 10 inhibitor concentrations. The degree of 
error in estimating the plateau values was maximal at the highest proportion of the B form (* 5%) and decreased to < 1% at values 
below 10% of the B form. 
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